Logo image of CNK

CINEMARK HOLDINGS INC (CNK) Stock Fundamental Analysis

USA - NYSE:CNK - US17243V1026 - Common Stock

25.27 USD
+0.18 (+0.72%)
Last: 10/14/2025, 11:42:52 AM
Fundamental Rating

5

Overall CNK gets a fundamental rating of 5 out of 10. We evaluated CNK against 79 industry peers in the Entertainment industry. CNK scores excellent on profitability, but there are concerns on its financial health. CNK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CNK had positive earnings in the past year.
In the past year CNK had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CNK reported negative net income in multiple years.
Of the past 5 years CNK 4 years had a positive operating cash flow.
CNK Yearly Net Income VS EBIT VS OCF VS FCFCNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.88%, CNK belongs to the top of the industry, outperforming 81.01% of the companies in the same industry.
CNK has a better Return On Equity (64.49%) than 97.47% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.81%, CNK belongs to the top of the industry, outperforming 86.08% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CNK is below the industry average of 9.15%.
The 3 year average ROIC (5.91%) for CNK is below the current ROIC(9.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.88%
ROE 64.49%
ROIC 9.81%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
CNK Yearly ROA, ROE, ROICCNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

With an excellent Profit Margin value of 8.98%, CNK belongs to the best of the industry, outperforming 81.01% of the companies in the same industry.
In the last couple of years the Profit Margin of CNK has grown nicely.
Looking at the Operating Margin, with a value of 12.82%, CNK belongs to the top of the industry, outperforming 81.01% of the companies in the same industry.
CNK's Operating Margin has been stable in the last couple of years.
The Gross Margin of CNK (64.08%) is better than 73.42% of its industry peers.
In the last couple of years the Gross Margin of CNK has remained more or less at the same level.
Industry RankSector Rank
OM 12.82%
PM (TTM) 8.98%
GM 64.08%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
CNK Yearly Profit, Operating, Gross MarginsCNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CNK is still creating some value.
Compared to 1 year ago, CNK has more shares outstanding
The number of shares outstanding for CNK has been increased compared to 5 years ago.
Compared to 1 year ago, CNK has an improved debt to assets ratio.
CNK Yearly Shares OutstandingCNK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CNK Yearly Total Debt VS Total AssetsCNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

CNK has an Altman-Z score of 1.25. This is a bad value and indicates that CNK is not financially healthy and even has some risk of bankruptcy.
CNK has a Altman-Z score of 1.25. This is comparable to the rest of the industry: CNK outperforms 53.16% of its industry peers.
The Debt to FCF ratio of CNK is 8.05, which is on the high side as it means it would take CNK, 8.05 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CNK (8.05) is comparable to the rest of the industry.
A Debt/Equity ratio of 4.40 is on the high side and indicates that CNK has dependencies on debt financing.
CNK has a Debt to Equity ratio of 4.40. This is in the lower half of the industry: CNK underperforms 79.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.4
Debt/FCF 8.05
Altman-Z 1.25
ROIC/WACC1.41
WACC6.97%
CNK Yearly LT Debt VS Equity VS FCFCNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 0.91 indicates that CNK may have some problems paying its short term obligations.
CNK's Current ratio of 0.91 is in line compared to the rest of the industry. CNK outperforms 40.51% of its industry peers.
CNK has a Quick Ratio of 0.91. This is a bad value and indicates that CNK is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.88, CNK perfoms like the industry average, outperforming 41.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.88
CNK Yearly Current Assets VS Current LiabilitesCNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

CNK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.66%, which is quite impressive.
Measured over the past 5 years, CNK shows a small growth in Earnings Per Share. The EPS has been growing by 4.49% on average per year.
CNK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.80%.
The Revenue has been decreasing by -1.47% on average over the past years.
EPS 1Y (TTM)88.66%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%96.88%
Revenue 1Y (TTM)13.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%28.1%

3.2 Future

The Earnings Per Share is expected to grow by 7.71% on average over the next years.
The Revenue is expected to grow by 5.28% on average over the next years.
EPS Next Y-27.37%
EPS Next 2Y3.19%
EPS Next 3Y7.71%
EPS Next 5YN/A
Revenue Next Year7.27%
Revenue Next 2Y7.48%
Revenue Next 3Y6.52%
Revenue Next 5Y5.28%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNK Yearly Revenue VS EstimatesCNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
CNK Yearly EPS VS EstimatesCNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.81, which indicates a correct valuation of CNK.
Based on the Price/Earnings ratio, CNK is valued cheaply inside the industry as 83.54% of the companies are valued more expensively.
CNK's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.34.
The Price/Forward Earnings ratio is 11.69, which indicates a very decent valuation of CNK.
Based on the Price/Forward Earnings ratio, CNK is valued cheaper than 91.14% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, CNK is valued a bit cheaper.
Industry RankSector Rank
PE 13.81
Fwd PE 11.69
CNK Price Earnings VS Forward Price EarningsCNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNK is valued cheaper than 82.28% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CNK is valued cheaper than 92.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.54
EV/EBITDA 7.23
CNK Per share dataCNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CNK has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.08
EPS Next 2Y3.19%
EPS Next 3Y7.71%

3

5. Dividend

5.1 Amount

CNK has a Yearly Dividend Yield of 1.20%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 27.49, CNK pays a better dividend. On top of this CNK pays more dividend than 87.34% of the companies listed in the same industry.
With a Dividend Yield of 1.20, CNK pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.2%

5.2 History

CNK has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNK Yearly Dividends per shareCNK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y3.19%
EPS Next 3Y7.71%
CNK Yearly Income VS Free CF VS DividendCNK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CINEMARK HOLDINGS INC

NYSE:CNK (10/14/2025, 11:42:52 AM)

25.27

+0.18 (+0.72%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-31 2025-10-31/bmo
Inst Owners123.23%
Inst Owner Change-1.22%
Ins Owners2.08%
Ins Owner Change-0.8%
Market Cap2.91B
Analysts77.65
Price Target34.17 (35.22%)
Short Float %11.41%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 1.2%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date08-27 2025-08-27 (0.08)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.58%
Min EPS beat(2)-100.53%
Max EPS beat(2)-14.63%
EPS beat(4)1
Avg EPS beat(4)-4.7%
Min EPS beat(4)-100.53%
Max EPS beat(4)109.69%
EPS beat(8)4
Avg EPS beat(8)57.72%
EPS beat(12)6
Avg EPS beat(12)21.99%
EPS beat(16)7
Avg EPS beat(16)0.74%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)-0.41%
Revenue beat(4)2
Avg Revenue beat(4)0.86%
Min Revenue beat(4)-1.25%
Max Revenue beat(4)3.21%
Revenue beat(8)6
Avg Revenue beat(8)1.89%
Revenue beat(12)9
Avg Revenue beat(12)2.59%
Revenue beat(16)12
Avg Revenue beat(16)2.59%
PT rev (1m)0%
PT rev (3m)0.68%
EPS NQ rev (1m)-0.53%
EPS NQ rev (3m)-22.07%
EPS NY rev (1m)-4.58%
EPS NY rev (3m)-14.63%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-6.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.71%
Valuation
Industry RankSector Rank
PE 13.81
Fwd PE 11.69
P/S 0.9
P/FCF 9.54
P/OCF 6.31
P/B 6.49
P/tB N/A
EV/EBITDA 7.23
EPS(TTM)1.83
EY7.24%
EPS(NY)2.16
Fwd EY8.55%
FCF(TTM)2.65
FCFY10.48%
OCF(TTM)4
OCFY15.84%
SpS27.97
BVpS3.89
TBVpS-9.54
PEG (NY)N/A
PEG (5Y)3.08
Profitability
Industry RankSector Rank
ROA 5.88%
ROE 64.49%
ROCE 11.34%
ROIC 9.81%
ROICexc 13.19%
ROICexgc 30.77%
OM 12.82%
PM (TTM) 8.98%
GM 64.08%
FCFM 9.47%
ROA(3y)1.43%
ROA(5y)-2.94%
ROE(3y)-43.93%
ROE(5y)-67.71%
ROIC(3y)5.91%
ROIC(5y)N/A
ROICexc(3y)7.77%
ROICexc(5y)N/A
ROICexgc(3y)16.27%
ROICexgc(5y)N/A
ROCE(3y)6.83%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y17.77%
ROICexc growth 3YN/A
ROICexc growth 5Y8.59%
OM growth 3YN/A
OM growth 5Y-0.86%
PM growth 3YN/A
PM growth 5Y11.48%
GM growth 3Y-0.83%
GM growth 5Y0.4%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 4.4
Debt/FCF 8.05
Debt/EBITDA 3.23
Cap/Depr 79.01%
Cap/Sales 4.84%
Interest Coverage 2.98
Cash Conversion 75.53%
Profit Quality 105.54%
Current Ratio 0.91
Quick Ratio 0.88
Altman-Z 1.25
F-Score6
WACC6.97%
ROIC/WACC1.41
Cap/Depr(3y)64.73%
Cap/Depr(5y)52.5%
Cap/Sales(3y)4.78%
Cap/Sales(5y)6.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.66%
EPS 3YN/A
EPS 5Y4.49%
EPS Q2Q%96.88%
EPS Next Y-27.37%
EPS Next 2Y3.19%
EPS Next 3Y7.71%
EPS Next 5YN/A
Revenue 1Y (TTM)13.8%
Revenue growth 3Y26.39%
Revenue growth 5Y-1.47%
Sales Q2Q%28.1%
Revenue Next Year7.27%
Revenue Next 2Y7.48%
Revenue Next 3Y6.52%
Revenue Next 5Y5.28%
EBIT growth 1Y52.76%
EBIT growth 3YN/A
EBIT growth 5Y-2.31%
EBIT Next Year74.37%
EBIT Next 3Y28.13%
EBIT Next 5Y16.59%
FCF growth 1Y40.92%
FCF growth 3Y64.6%
FCF growth 5Y4.05%
OCF growth 1Y35.07%
OCF growth 3Y41.01%
OCF growth 5Y-3.68%